CYBB and neoplasm: The subsequent reduction in ROS-mediated receptor tyrosine kinase (RTK) signaling results in the regression of tumor growth in mouse models of lung tumors [124], suggesting BJ-1301-mediated NOX2 inhibition as a promising anti-cancer therapeutics approach.